Glioblastoma is the most common malignant brain tumor, characterized by growth, development of blood vessels and invasion ...

Brain cancer is the sixth deadliest cancer in the United States, with a survival rate of only 33.8%. According to the ...

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy—which involves ...

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer.

Craniopharyngioma (CP), although histologically benign, is a surgically challenging sellar-region tumor for which stereotactic irradiation is increasingly used as an alternative or adjuvant strategy.

Using human cells and cutting-edge technology, the team created a three-dimensional (3D) model that accurately simulates the ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

Patritumab deruxtecan shows meaningful clinical activity in heavily pretreated patients with metastatic breast cancer and ...

Jeannine Walston, who has contributed to CURE since 2015, was diagnosed with a brain tumor in March 1998. Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has ...

Karen Tait started experiencing severe symptoms in October 2022 that left her bedridden Doctors told her multiple times that she was suffering from depression, menopause or fibromyalgia Two years ...